← Retour au Screener

Sector: Santé
Open in Terminal → MDTLive chart · Key metrics · News · Smart money

Medtronic plc.

MDT Large Cap

Healthcare · Medical Devices

Mis à jour: Jun 18, 2026, 22:21 UTC

69,15 €
+1.51% aujourd'hui
52W: 63,91 € – 92,69 €
52W Low: 63,91 € Position: 18.2% 52W High: 92,69 €

Price Chart

Indicateurs clés

P/E Ratio
21.04x
Cours/Bénéfice
Forward P/E
12.38x
P/E prévisionnel
P/S Ratio
2.8x
Cours/Ventes
EV/EBITDA
12.33x
Valeur d'entreprise/EBITDA
Rend. dividende
3.63%
Rendement annuel du dividende
Cap. boursière
88,8 Md €
Capitalisation boursière
Croissance du CA
9.9%
Croissance du CA sur un an
Marge bénéficiaire
13.2%
Marge nette
ROE
9.93%
Rentabilité des capitaux propres
Beta
0.6
Sensibilité au marché
Positions vendeuses
1.31%
% du flottant vendu à découvert
Volume moyen
9,887,763
Volume quotidien moyen

Valuation Analysis

Signal
Fair
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
Acheter
26 analysts
Avg. Price Target
85,43 €
+23.55% upside
Target Range
68,00 € – 105,48 €

About the Company

Sector: Healthcare Industry: Medical Devices Country: Ireland Employees: 95,000 Exchange: NYQ

Medtronic plc. en bref

Medtronic plc. (MDT) is currently trading at 69,15 € with a market capitalization of 88,8 Md €. The trailing P/E ratio stands at 21.04x, with a forward P/E of 12.38x. The 52-week range spans from 63,91 € to 92,69 €; the current price is 25.4% below the yearly high. Year-over-year revenue growth stands at +9.9%. The net profit margin stands at 13.2%.

💰 Dividende

Medtronic plc. pays an annual dividend of 2,51 € per share, representing a yield of 3.63%. The payout ratio stands at 76.14%.

📊 Avis des analystes

26 analystes évaluent Medtronic plc. (MDT) au consensus : Acheter. L'objectif de cours moyen est de 85,43 €, soit un potentiel de +23.55% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 68,00 € à 105,48 €.

Medtronic plc. : la thèse d'investissement en détail

Medtronic plc. (MDT) operates in the Healthcare — specifically Medical Devices — and is headquartered in Ireland. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

With a gross margin near 65.38%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns. Wall Street consensus sits at Buy with an average price target implying roughly 23.55% upside from current levels — analyst sentiment is firmly constructive.

À surveiller

  • The forward P/E of 12.38x is meaningfully below the trailing 21.04x — analysts expect earnings to step up; the next earnings release is the test.
  • The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
  • The analyst consensus price target implies 23.55% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Points forts
  • Marge brute élevée de 65.38% — signe d'un pouvoir de fixation des prix
  • Consensus des analystes : Buy
  • Rendement du dividende solide de 3.63%
Points faibles

Aucun signal d'alerte significatif dans les indicateurs actuels.

Aperçu technique

MM 50 jours
70,02 €
-1.25% vs. cours
MM 200 jours
80,18 €
-13.76% vs. cours
Sous le plus haut 52s
−25.4%
92,69 €
Au-dessus du plus bas 52s
+8.2%
63,91 €

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

Risque de marché (Bêta)
0.6 · Défensive
Évolue moins que le marché global
Positions vendeuses
1.31% · Faible
% du flottant vendu à découvert
Dette/Capitaux propres
57.06 · Modéré
Dette totale / capitaux propres

The data points to relatively defensive market behavior.

Trading Data

50-Day MA: 70,02 €
200-Day MA: 80,18 €
Volume: 8,261,406
Avg. Volume: 9,887,763
Short Ratio: 1.56
P/B Ratio: 2.08x
Debt/Equity: 57.06x
Free Cash Flow:

💵 Dividend Info

Dividend Yield
3.63%
Annual Rate
2,51 €
Payout Ratio
76.14%

More Santé stocks

Top peers in the same sector — ranked by market cap.

View full Santé sector page →

Where can I buy Medtronic plc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Live Market Data

Real-time chart, financials, earnings, analysts, insider trades, events & news

Financials

Earnings

Analyst Ratings

Insider Trades

Events Timeline

News + Sentiment

Peer Comparison

Retour en haut